Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis/cystitis treated by ureteral stent and review of the literature
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of systemic cancer therapy. During disinhibiting the antitumor responses of immune system, ICIs may also cause unique immune-related adverse events (irAEs) which could affect any organ. Here, we report a rare case of sintilimab-in...
Saved in:
Main Authors: | Jiaxiang Ji, Chin-Hui Lai, Xiaowei Zhang, Hao Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1501415/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Initial experience of a novel ureteral silicon-covered metallic mesh stent in malignant ureteric obstruction: a single-center retrospective study
by: Chung Un Lee, et al.
Published: (2024-12-01) -
Allium covered metal stent for treatment of malignant ureteral obstruction
by: Jing Qing, et al.
Published: (2024-11-01) -
Exploring Condition-Specific Variability in the Ureteral Stent Microbiome
by: Ava Mousavi, et al.
Published: (2024-10-01) -
Cost‐effectiveness of Resonance® metallic ureteral stent compared with standard polyurethane ureteral stents in malignant ureteric obstruction: A cost‐utility analysis
by: Dawn M. Cooper, et al.
Published: (2024-05-01) -
Use of metallic ureteric stents for chronic ureteric obstruction and its association with value-based care
by: Yu Xi Terence Law, et al.
Published: (2025-01-01)